Download MendeleyDesign and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents.
Sealy, J.M., Truong, A.P., Tso, L., Probst, G.D., Aquino, J., Hom, R.K., Jagodzinska, B.M., Dressen, D., Wone, D.W., Brogley, L., John, V., Tung, J.S., Pleiss, M.A., Tucker, J.A., Konradi, A.W., Dappen, M.S., Toth, G., Pan, H., Ruslim, L., Miller, J., Bova, M.P., Sinha, S., Quinn, K.P., Sauer, J.M.(2009) Bioorg Med Chem Lett 19: 6386-6391
- PubMed: 19811916
- DOI: https://doi.org/10.1016/j.bmcl.2009.09.061
- Primary Citation of Related Structures:
3IVH, 3IVI - PubMed Abstract:
Using structure-guided design, hydroxyethylamine BACE-1 inhibitors were optimized to nanomolar Abeta cellular inhibition with selectivity against cathepsin-D. X-ray crystallography illuminated the S1' residues critical to this effort, which culminated in compounds 56 and 57 that exhibited potency and selectivity but poor permeability and high P-gp efflux.
Organizational Affiliation:
Department of Medicinal Chemistry, Elan Pharmaceuticals, 180 Oyster Point Boulevard, South San Francisco, CA 94080, USA.
